Stockholm, June 24, 2010 — NASDAQ OMX (NASDAQ:NDAQ) announced that Oasmia Pharmaceutical AB (OASM), a Small Cap company within the Biotech sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Oasmia is the twelfth company to list on NASDAQ OMX in Europe in 2010. To view and download pictures from today's listing ceremony please visit: http://bit.ly/cTEgA3 Oasmia Pharmaceutical AB is based in Sweden and was founded in 1999. Oasmia develops a new generation of pharmaceuticals with the emphasis on human and veterinary oncology, with a vision to improve treatments of severe diseases. For more information about Oasmia, please visit www.oasmia.com Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are very pleased to welcome Oasmia to our main market, one of Europe's most liquid cash equities markets. We look forward to supporting Oasmia in increasing their investor visibility as well as their reach to the global capital markets.” Julian Aleksov, CEO Oasmia commented, “We are very happy to have our share listed today. The switch from NGM to NASDAQ OMX gives Oasmia yet another quality mark on the importance of our research, our unique products and the company itself. It also provides more investors with a possibility to invest in Swedish-based pharmaceutical development.” About NASDAQ OMX The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx). Cautionary Note Regarding Forward-Looking Statements The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements. - # - CONTACTS: The NASDAQ OMX Group, Inc. Anna Rasin +46 8 405 66 12 email@example.com
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.